Join ChemPartner July 23rd for a new summer webinar!
In this Fierce webinar, ChemPartner expert Dr. Philip Clarke, PhD, will highlight advances in next‑generation conjugation across emerging modalities beyond traditional ADCs.
The 1 hour presentation will cover innovations in peptide conjugates, oligonucleotide (ON) targeting, PROTACs and more. A live Q&A will follow the webinar offering you a chance to pose questions to our expert panelists.
Time: Thursday July 23, 2026, 11:00 AM ET
Speaker:
Phil Clarke, PhD, Associate Director, Scientific Communications, ChemPartner
Dr. Clarke is an Associate Director of scientific communications at ChemPartner, where he supports both scientific and commercial teams through troubleshooting, project management of chemistry programs, and the generation of scientific content.
Clarke completed his PhD in synthetic organic chemistry at the University of Southampton in 2003, under the supervision of Bruno Linclau, PhD, focusing on asymmetric Diels–Alder methodology.
Prior to joining ChemPartner, Phil held leadership roles at Concept Life Sciences and Charnwood Discovery, where he managed drug discovery projects, developed high-performing teams, and delivered innovative chemistry solutions across a range of therapeutic areas.
With over two decades of experience in chemistry and scientific strategy, he brings a deep understanding of drug development and a passion for translating complex science into impactful communication.